List view / Grid view
22 October 2014 | By Distributed by APO (African Press Organization) on behalf of Rotary International
With a 90 percent reduction in polio cases, Nigeria is close to ending transmission of the poliovirus...
22 October 2014 | By GlobalData
The recent US Food and Drug Administration approval of Harvoni (ledipasvir/sofosbuvir), Gilead Sciences’ once-daily, single-tablet regimen to treat chronic hepatitis C virus (HCV) genotype 1 (GT1) infection in adults, will enable the company to maintain its dominance in an increasingly competitive market...
22 October 2014 | By NYU Langone Medical Center
Researchers at NYU Langone Medical Center and elsewhere say that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia...
22 October 2014 | By GlobalData
The loss of patent exclusivity on several key branded products and the lack of novel drugs will result in minimal growth of the allergic conjunctivitis treatment market, from $1.37 billion in 2013 to $1.44 billion by 2018...
22 October 2014 | By Distributed by APO (African Press Organization) on behalf of Merck KGaA
The Merck Capacity Advancement Program was kicked off successfully in 7 sub- Saharan countries...
22 October 2014 | By Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc
Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc. presented new evidence supporting the use of Latuda® (lurasidone), an atypical antipsychotic treatment for adults with schizophrenia, during multiple poster sessions at the 27th European College of Neuropsychopharmacology...
22 October 2014 | By APO (African Press Organization) on behalf of The Economist Events
The Economist Events will be hosting their Health Care in Africa Summit in Dar es Salaam, Tanzania at the Hyatt Regency, The Kilimanjaro on November 18th and 19th 2014...
22 October 2014 | By Roche
Investments of 3 billion Swiss francs in modern research infrastructure, attractive workplaces and sustainable site development...
22 October 2014 | By Frost & Sullivan
Etienne van Wyk, Programme Manager for Healthcare at Frost & Sullivan Africa, comments on the current outbreak and its long term implications...
21 October 2014 | By Boehringer Ingelheim
Boehringer Ingelheim today announced the enrolment of the first patient in a new global Phase III study in patients with advanced colorectal cancer...
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, successfully closed the first nine months of 2014 with substantial gains.
21 October 2014 | By Calixar
Aston University (Birmingham - UK) and Calixar SAS (Lyon-France) have concluded a new research agreement through the “BBSRC Industrial CASE Studentship Competition 2013” framework...
21 October 2014 | By Amgen
Amgen announced the appointment of R. Sanders Williams, M.D., president of Gladstone Institutes and Gladstone's Robert W. and Linda L. Mahley Distinguished Professor...
21 October 2014 | By The European Medicines Agency
EMA encourages companies to apply for orphan designation...
20 October 2014 | By Doctors of the World UK
A new report by the think-tank Demos, supported by Doctors of the World, argues that encouraging earlier detection of health conditions amongst migrant communities would reduce NHS spending on treatment and reduce the wider public health risk by catching transmittable diseases early...
